Financing to accelerate Aiforia’s development and continuing expansion of AI solutions for image analysis in clinical diagnostics and preclinical pathology. HELSINKI, Sept 16, 2021 -- Aiforia, a software company providing AI-based solutions...

CompuMed launches a project to evaluate the use of AI through Aiforia’s cloud-based software to enhance the speed and accuracy of pathology evaluation in organ transplantation. CompuMed and its team of highly experienced physicians provide...

The CE-IVD marked AI model for Ki67 is the first model to be released as part of the Aiforia Clinical Suite for Breast Cancer, supporting pathologists in cancer diagnosis. First-of-its kind diagnostic tool Aiforia today announced the CE-IVD...

Helsinki, Finland - Aiforia is currently recruiting for multiple positions. Who is Aiforia? Aiforia equips pathologists and scientists in pre-clinical, academic, and clinical labs with the most powerful deep learning artificial intelligence...

Singapore, Helsinki – Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible...

What additional benefit does AI bring to the digitized pathology workflow in clinical diagnostics? Read our article to find out. Rising rates of disease like cancer increase sample numbers creating a bigger burden on pathologists, an...